V
Venkata Viswanadh Edara
Researcher at Emory University
Publications - 37
Citations - 4545
Venkata Viswanadh Edara is an academic researcher from Emory University. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 11, co-authored 17 publications receiving 1404 citations. Previous affiliations of Venkata Viswanadh Edara include Yerkes National Primate Research Center.
Papers
More filters
Journal ArticleDOI
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
Evan J. Anderson,Nadine Rouphael,Alicia T. Widge,Lisa A. Jackson,Paul C. Roberts,Mamodikoe Makhene,James D. Chappell,Mark R. Denison,Laura J. Stevens,Andrea J. Pruijssers,Adrian B. McDermott,Britta Flach,Bob C. Lin,Nicole A. Doria-Rose,Sijy O'Dell,Stephen D. Schmidt,Kizzmekia S. Corbett,Phillip A. Swanson,Marcelino Padilla,Kathy M. Neuzil,Hamilton Bennett,Brett A. Leav,Mat Makowski,Jim Albert,Kaitlyn Cross,Venkata Viswanadh Edara,Katharine Floyd,Mehul S. Suthar,David R. Martinez,Ralph S. Baric,Wendy Buchanan,Catherine J. Luke,Varun K Phadke,Christina A. Rostad,Julie E. Ledgerwood,Barney S. Graham,John H. Beigel +36 more
TL;DR: The phase 1, dose-escalation, open-label trial of a messenger RNA vaccine, mRNA-1273, which encodes the stabilized prefusion SARS-CoV-2 spike protein in healthy adults found it induced higher binding- and neutralizing-antibody titers than the 25-μg dose, which supports the use of the 100- μg dose in a phase 3 vaccine trial.
Journal ArticleDOI
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
Alicia T. Widge,Nadine Rouphael,Lisa A. Jackson,Evan J. Anderson,Paul C. Roberts,Mamodikoe Makhene,James D. Chappell,Mark R. Denison,Laura J. Stevens,Andrea J. Pruijssers,Adrian B. McDermott,Britta Flach,Bob C. Lin,Nicole A. Doria-Rose,Sijy O'Dell,Stephen D. Schmidt,Kathleen M. Neuzil,Hamilton Bennett,Brett Leav,Mat Makowski,Jim Albert,Kaitlyn Cross,Venkata Viswanadh Edara,Katharine Floyd,Mehul S. Suthar,Wendy Buchanan,Catherine J. Luke,Julie E. Ledgerwood,John R. Mascola,Barney S. Graham,John H. Beigel +30 more
TL;DR: A small number of adults received two 100-μg injections of Moderna’s mRNA SARS-CoV-2 vaccine, and serum anti–spike protein and neutralizing antibody titers revealed immunogenicity and safety concerns.
Journal ArticleDOI
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
Nicole A. Doria-Rose,Mehul S. Suthar,Mat Makowski,Sarah O’Connell,Adrian B. McDermott,Britta Flach,Julie E. Ledgerwood,John R. Mascola,Barney S. Graham,Bob C. Lin,Sijy O'Dell,Stephen D. Schmidt,Alicia T. Widge,Venkata Viswanadh Edara,Evan J. Anderson,Evan J. Anderson,Lilin Lai,Katharine Floyd,Nadine Rouphael,Veronika I. Zarnitsyna,Paul C. Roberts,Mamodikoe Makhene,Wendy Buchanan,Catherine J. Luke,John H. Beigel,Lisa A. Jackson,Kathleen M. Neuzil,Hamilton Bennett,Brett Leav,Jim Albert,Pratap Kunwar +30 more
TL;DR: A total of 33 participants who received both doses of the Moderna mRNA-1273 vaccine against SARS-CoV-2 had blood drawn over a period of 6 months.
Journal ArticleDOI
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Peter Halfmann,Shun Iida,Kiyoko Iwatsuki-Horimoto,Tadashi Maemura,Maki Kiso,Suzanne M. Scheaffer,Tamarand L. Darling,Astha Joshi,Samantha Loeber,Gagandeep Singh,Stephanie L. Foster,Baoling Ying,James Brett Case,Zhenlu Chong,Bradley M. Whitener,Juan I. Moliva,Katharine Floyd,Michiko Ujie,Noriko Nakajima,Mutsumi Ito,R. Wright,Ryuta Uraki,Prajakta Warang,Matthew Gagne,Rongxiu Li,Yuko Sakai-Tagawa,Yanan Liu,Deanna Larson,Jorge E. Osorio,Juan P. Hernández-Ortiz,Amy R. Henry,Karl A Ciuoderis,Kelsey Florek,Mit Patel,Abby E. Odle,Lok-Yin Roy Wong,Allen C. Bateman,Zhongde Wang,Venkata Viswanadh Edara,John Franks,Trushar Jeevan,Thomas P. Fabrizio,Jennifer DeBeauchamp,Lisa Kercher,Patrick Seiler,Ana S. Gonzalez-Reiche,Emilia Mia Sordillo,Lauren A. Chang,Harm van Bakel,Viviana Simon,Bremy Alburquerque,Hala Alshammary,Angela Amoako,Shiraz Aslam,Radhika N. Banu,Cecilia Cognigni,Marlene Espinoza-Moraga,K. Farrugia,Adriana van de Guchte,Z. Khalil,Manon Laporte,Ignacio Mena,Alberto Paniz-Mondolfi,Jose Polanco,A.A. “Sonny” Rooker,L. Sominsky,Daniel C. Douek,Nancy J. Sullivan,Larissa B. Thackray,Hiroshi Ueki,Seiya Yamayoshi,Masaki Imai,Stanley Perlman,Richard J. Webby,Robert A. Seder,Mehul S. Suthar,Adolfo García-Sastre,Michael Schotsaert,Tadaki Suzuki,Adrianus C. M. Boon,Michael S. Diamond,Yoshihiro Kawaoka +81 more
TL;DR: In this paper , the authors evaluated the ability of several B.1.529 isolates to cause infection and disease in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters.
Journal ArticleDOI
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.
Kristen W. Cohen,Susanne L. Linderman,Zoe Moodie,Julie Czartoski,Lilin Lai,Lilin Lai,Grace Mantus,Carson Norwood,Lindsay E. Nyhoff,Venkata Viswanadh Edara,Venkata Viswanadh Edara,Katharine Floyd,Katharine Floyd,Stephen C. De Rosa,Stephen C. De Rosa,Hasan Ahmed,Rachael E. Whaley,Shivan N. Patel,Brittany Prigmore,Maria P. Lemos,Carl W. Davis,Sarah Furth,James B O'Keefe,Mohini P. Gharpure,Sivaram Gunisetty,Kathy Stephens,Rustom Antia,Veronika I. Zarnitsyna,David S. Stephens,Srilatha Edupuganti,Nadine Rouphael,Evan J. Anderson,Aneesh K. Mehta,Jens Wrammert,Mehul S. Suthar,Mehul S. Suthar,Rafi Ahmed,M. Juliana McElrath,M. Juliana McElrath +38 more
TL;DR: In this article, the authors evaluated 254 COVID-19 patients longitudinally up to 8 months and found durable broad-based immune responses to SARS-CoV-2 infection.